Sentences with phrase «favorable cytogenetic»

Those with uninformative cytogenetic or molecular markers with negative minimal residual disease at the end of induction were noted to experience the most benefit (nearly 2-fold benefit from receiving a fifth dose of chemotherapy) vs. those with favorable cytogenetic and molecular features who did not experience benefit from receiving a fifth dose of therapy.

Among patients with favorable cytogenetic and molecular features, the point estimates for disease - free survival and overall survival were approximately 1, indicating no benefit of a fifth course of chemotherapy, Getz said.